MARKET

PHAR

PHAR

Pharming Group N.V.
NASDAQ
15.52
+1.01
+6.96%
Opening 14:05 03/16 EDT
OPEN
15.19
PREV CLOSE
14.51
HIGH
15.52
LOW
14.65
VOLUME
60.51K
TURNOVER
--
52 WEEK HIGH
21.34
52 WEEK LOW
7.50
MARKET CAP
1.06B
P/E (TTM)
388.00
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at PHAR last week (0309-0313)?
Weekly Report · 10h ago
Pharming Group Price Target Cut to $41.00/Share From $42.00 by Oppenheimer
Dow Jones · 3d ago
Oppenheimer Reiterates Outperform on Pharming, Lowers Price Target to $41
Benzinga · 3d ago
Pharming price target lowered to $41 from $42 at Oppenheimer
TipRanks · 3d ago
Analysts Offer Insights on Healthcare Companies: Solid Biosciences (SLDB), Korro Bio (KRRO) and Pharming Group (PHAR)
TipRanks · 3d ago
Pharming outlines $405M–$425M 2026 revenue target as Joenja and RUCONEST drive growth
Seeking Alpha · 4d ago
Pharming: Solid Execution, Resilient Revenue, and Joenja Growth Support Buy Rating Ahead of Key Leniolisib Catalysts
TipRanks · 4d ago
Pharming Group Posts Strong 2025 Growth, Turns Profitable and Lifts 2026 Outlook
TipRanks · 4d ago
More
About PHAR
Pharming Group NV is a biopharmaceutical company based in the Netherlands. The Company is engaged in the development, production and commercialization of human therapeutic proteins to be used in the therapies. The Company's product portfolio is aimed at treatments for genetic disorders, blood-related disorders, infectious and inflammatory diseases, tissue and bone damage and surgical/traumatic bleeding. Its core product, RUCONEST (conestat alfa) is a recombinant human C1 esterase inhibitor approved for the treatment of acute Hereditary Angioedema (HAE) attacks in patients in Europe, the Unites States, Israel and South Korea. The product is available on a named-patient basis in other territories where it has not yet obtained marketing authorization.

Webull offers Pharming Group NV stock information, including NASDAQ: PHAR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PHAR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PHAR stock methods without spending real money on the virtual paper trading platform.